Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis (Q30276131)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis |
scientific article |
Statements
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis (English)
Merit E Cudkowicz
Srividya Ramachandran
Christopher S Coffey
Trevis Gleason
Andrew Goodman
Eric C Klawiter
Kazuko Matsuda
Michelle McGovern
Robin Conwit
Robert Naismith
Akshata Ashokkumar
Robert Bermel
Dixie Ecklund
Maxine Koepp
Sneha Natarajan
Thomai Skaramagas
Brenda Thornell
Jon Yankey
Mark Agius
Khurram Bashir
Bruce Cohen
Patricia Coyle
Silvia Delgado
Dana Dewitt
Angela Flores
Barbara Giesser
Myla Goldman
Burk Jubelt
Neil Lava
Sharon Lynch
Augusto Miravalle
Harold Moses
Jai Perumal
Michael Racke
Pavle Repovic
Claire Riley
Christopher Severson
Shlomo Shinnar
Valerie Suski
Bianca Weinstock-Gutman
Vijayshree Yadav
10 August 2016
1 reference
1 reference
1 reference